Diagnosis of Fanconi Anemia: Mutation Analysis by Next-Generation Sequencing
Open Access
- 3 June 2012
- journal article
- research article
- Published by Hindawi Limited in Anemia
- Vol. 2012, 1-7
Abstract
Fanconi anemia (FA) is a rare genetic instability syndrome characterized by developmental defects, bone marrow failure, and a high cancer risk. Fifteen genetic subtypes have been distinguished. The majority of patients (≈85%) belong to the subtypes A (≈60%), C (≈15%) or G (≈10%), while a minority (≈15%) is distributed over the remaining 12 subtypes. All subtypes seem to fit within the “classical” FA phenotype, except for D1 and N patients, who have more severe clinical symptoms. Since FA patients need special clinical management, the diagnosis should be firmly established, to exclude conditions with overlapping phenotypes. A valid FA diagnosis requires the detection of pathogenic mutations in a FA gene and/or a positive result from a chromosomal breakage test. Identification of the pathogenic mutations is also important for adequate genetic counselling and to facilitate prenatal or preimplantation genetic diagnosis. Here we describe and validate a comprehensive protocol for the molecular diagnosis of FA, based on massively parallel sequencing. We used this approach to identifyBRCA2,FANCD2,FANCIandFANCLmutations in novel unclassified FA patients.Keywords
This publication has 17 references indexed in Scilit:
- VarScan: variant detection in massively parallel sequencing of individual and pooled samplesBioinformatics, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Next-Generation Sequencing: From Basic Research to DiagnosticsClinical Chemistry, 2009
- Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteinsNature Reviews Genetics, 2007
- Hypomorphic Mutations in the Gene Encoding a Key Fanconi Anemia Protein, FANCD2, Sustain a Significant Group of FA-D2 Patients with Severe PhenotypeThe American Journal of Human Genetics, 2007
- Fanconi anemia is associated with a defect in the BRCA2 partner PALB2Nature Genetics, 2006
- Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutralJournal of Medical Genetics, 2005
- Biallelic Inactivation of BRCA2 in Fanconi AnemiaScience, 2002
- Screening for BRCA2 mutations in 81 Dutch breast–ovarian cancer familiesBritish Journal of Cancer, 2000